The present invention is directed to novel nanomolar and picomolar inhibitors of HIV reverse transcriptase, pharmaceutical compositions therefrom and methods for inhibiting reverse transcriptase and treating HIV infections, especially included drug resistant strains of HIV-1 and HIV-2 and/or secondary disease states and/or conditions which occur as a consequence of HIV infection.
本发明涉及新型纳摩尔和皮摩尔级别的HIV
反转录酶抑制剂,其制药组合物以及抑制
反转录酶和治疗HIV感染的方法,特别包括对HIV-1和HIV-2的耐药菌株和/或作为HIV感染后果的二级疾病状态和/或条件的治疗。